Meyka Pro banner
Labcorp Holdings Inc.

Labcorp Holdings Inc. (LH) Stock Overview

Explore Labcorp Holdings Inc.’s financial performance, market position, analyst ratings, and future outlook.

LH●NYSE
HealthcareMedical - Diagnostics & Research
$372.46
$1.98(0.53%)
U.S. Market opens in NaNh NaNm

Labcorp Holdings Inc. (LH)

Meyka AI Score

Z

Key Financials

Market Cap30.3B
P/E Ratio30.29
EPS (TTM)$16.85
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$374.18
3 Months$312.26
1 Year Target$293.26

LH Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Labcorp Holdings Inc. (NYSE: LH) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Labcorp Holdings Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LH on the NYSE shows an RSI of 70.78, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $293.26 for the NYSE listing.

Key metrics behind Labcorp Holdings Inc.'s NYSE-traded stock include a P/E ratio of 30.29 and a market capitalization of 30.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of LH on the NYSE.

Price Performance (NYSE: LH)

1-Day Change
0.56%
5-Day Change
0.87%
1-Month Change
17.17%
3-Month Change
17.11%
6-Month Change
48.78%
Year-to-Date (YTD) Change
48.50%
1-Year Change
42.54%
3-Year Change
76.79%
5-Year Change
50.39%
All-Time (Max) Change
1679.13%

Contact Information

336 229 1127
358 South Main Street, Burlington, NC, 27215

Company Facts

710,000 Employees
IPO DateMar 29, 1990
CountryUS
Actively Trading

Frequently Asked Questions